Bisphosphonates are primary agents in the current pharmacological arsenal against
osteoclast-mediated bone loss due to osteoporosis, Paget disease of bone, malignancies …

Advances in hematopoietic cell transplantation (HCT) technology and supportive care
techniques have led to improvements in long-term survival after HCT. Emerging indications …

Hematopoietic cell transplantation is a curative treatment for a variety of hematologic
diseases. Advances in transplantation technology have reduced early transplant-related …

Simple Summary Anti-cancer treatments induced an increase in the childhood cancer
survival rate. However, they are responsible for several long-term side effects in childhood …

Optimizing health outcomes, including prevention of osteoporotic fractures, is essential for
promoting the well-being of the growing number of cancer survivors. Medical providers who …

More than 25 000 allogeneic hematopoietic stem cell transplantations (allo-HCTs) are
expected to be performed worldwide in 2010, a number that has been increasing yearly …

Purpose The number of long-term survivors after hematopoietic stem-cell transplantation
(HSCT) for malignant and nonmalignant disorders is increasing, and late effects are gaining …

Alginate calcification has been previously reported clinically and during animal implantation;
however no study has investigated the mechanism, extensively characterized the mineral, or …

Bisphosphonates are chemically stable structural analogs of inorganic pyrophosphate.
Owing to their ability to inhibit osteoclast activity, bisphosphonates have become the primary …

Introduction Haematopoietic stem cell transplant (HSCT) in adults is an intensive medical
procedure for a variety of haematological malignancies. Although there is a large body of …